Globally, diabetic retinopathy (DR) is one of the leading causes of blindness, that diminishes quality of life. This study aimed to describe the prevalence of DR, and its associated risk factors. This cross-sectional study was carried out among 478 diabetic patients in a referral center in Fars province, Iran. The mean±standard deviation age of the participants was 56.64±12.45 years old and DR prevalence was 32.8%. In multivariable analysis, lower education levels (adjusted odds ratio [aOR], 0.43; 95% confidence interval [CI], 0.24 to 0.76), being overweight (aOR, 1.70; 95% CI, 1.02 to 2.83) or obese (aOR, 1.88; 95% CI, 1.09 to 3.26), diabetes duration of 10 to 20 years (aOR, 2.35; 95% CI, 1.48 to 3.73) and over 20 years (aOR, 5.63; 95% CI, 2.97 to 10.68), receiving insulin (aOR, 1.99; 95% CI, 1.27 to 3.10), and having chronic diseases (aOR, 1.71; 95% CI, 1.02 to 2.85) were significantly associated with DR. In conclusion, longer diabetes duration and obesity or having chronic diseases are strongly associated with DR suggesting that control of these risk factors may reduce both the prevalence and impact of retinopathy in Iran.

Citations

Citations to this article as recorded by  

• Glycemic control among Iranian people with type 2 diabetes: a systematic review and meta-analysis
  Mohammad Mohseni, Motahar Heidari-Beni, Roya Kelishadi
  International Journal of Diabetes in Developing Countries.2023; 43(4): 502.     CrossRef
• Single-Field Fundus Photography for Screening of Diabetic Retinopathy: The Prevalence and Associated Factors in a Population-Based Study
  Mohammadreza Soleimani, Fateme Alipour, Yousef Taghavi, Marjan Fatemipour, Hamid Hakimi, Zahra Jamali, Parvin Khalili, Fatemeh Ayoobi, Maryam Sheikh, Roya Tavakoli, Amin Zand
  Diabetes Therapy.2023; 14(1): 205.     CrossRef
• Diabetic peripheral neuropathy screening and the related risk factors to its prevalence in people with type 2 diabetes
  Mohamad Sabaghan, Shima Ataee, Maryam Ataee, Mahsa Tebyanian, Sima Afrashteh, Nima Daneshi
  International Journal of Diabetes in Developing Countries.2023; 43(5): 641.     CrossRef
• Direct medical cost and medications for patient of diabetes retinopathy in Beijing, China, 2016–2018
  Hui Li, Lina Zhang, Xiaoxia Wang, Weihao Wang, Jie Zhang, Qi Pan, Lixin Guo
  Diabetes Research and Clinical Practice.2023; 202: 110796.     CrossRef
• Preserving sight: Managing and preventing diabetic retinopathy
  Mohd Altaf Dar, Mudasir Maqbool, Irfat Ara, Zulfkar Qadrie
  Open Health.2023;[Epub]     CrossRef
• Global and Regional Prevalence of Diabetic Retinopathy; A Comprehensive Systematic Review and Meta-analysis
  Hassan Hashemi, Farhad Rezvan, Reza Pakzad, Asal Ansaripour, Samira Heydarian, Abbasali Yekta, Hadi Ostadimoghaddam, Mojgan Pakbin, Mehdi Khabazkhoob
  Seminars in Ophthalmology.2022; 37(3): 291.     CrossRef
• Prevalence and Factors Associated with Diabetic Retinopathy among Adult Diabetes Patients in Southeast Ethiopia: A Hospital-Based Cross-Sectional Study
  Biniyam Sahiledengle, Tesfaye Assefa, Wogene Negash, Anwar Tahir, Tadele Regasa, Yohannes Tekalegn, Ayele Mamo, Zinash Teferu, Damtew Solomon, Habtamu Gezahegn, Kebebe Bekele, Demisu Zenbaba, Alelign Tasew, Fikreab Desta, Zegeye Regassa, Zegeye Feleke, Ch
  Clinical Ophthalmology.2022; Volume 16: 3527.     CrossRef
• Prevalence of diabetic retinopathy in the Eastern Mediterranean Region: a systematic review and meta-analysis
  Alireza Heiran, Seyede Pegah Azarchehry, Saeid Dehghankhalili, Mehrdad Afarid, Sonia Shaabani, Alireza Mirahmadizadeh
  Journal of International Medical Research.2022; 50(10): 030006052211171.     CrossRef
• Performance of diabetes screening tests: an evaluation study of Iranian diabetes screening program
  Fateme Kianpour, Mohammad Fararouei, Jafar Hassanzadeh, Mohammadnabi Mohammadi, Mostafa Dianatinasab
  Diabetology & Metabolic Syndrome.2021;[Epub]     CrossRef
• Screening for diabetes and prediabetes: the newest communication opportunities
  V.I. Velychko, V.L. Mykhailenko, D.O. Lahoda, G.O. Volokhova, S.L. Liashenko
  REPRODUCTIVE ENDOCRINOLOGY.2021; (62): 92.     CrossRef

• Prevalence of Diabetic Retinopathy and Its Associated Factors among Diabetic Patients at Debre Markos Referral Hospital, Northwest Ethiopia, 2019: Hospital-Based Cross-Sectional Study

  
  Melkamu Tilahun, Teshome Gobena, Diriba Dereje, Mengistu Welde, Getachew Yideg
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 2179.     CrossRef
• Gastrointestinal symptoms in patients with diabetes mellitus and non-diabetic: A cross-sectional study in north of Iran
  Mehrnaz Asgharnezhad, Farahnaz Joukar, Mohammad Fathalipour, Mohammadjavad Khosousi, Soheil Hassanipour, Akram Pourshams, Roya Mansour-Ghanaei, Fariborz Mansour-Ghanaei
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(3): 2236.     CrossRef
• Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study
  Yoo-Ri Chung, Kyoung Hwa Ha, Hyeon Chang Kim, Sang Jun Park, Kihwang Lee, Dae Jung Kim
  Diabetes & Metabolism Journal.2019; 43(5): 640.     CrossRef